Back to Department of Radiation Oncology
It's All Translational
That conviction drives the research in our Cancer Biology, Molecular Imaging and Physics Divisions as well as in the Clinical Division where the most obvious translation occurs.
Our scientists believe that their work in genomics or metabolomics or cancer cell biology is as much about improving cancer therapy as are quality of life studies and testing of new combination therapies or novel agents. Our physicists have been and continue to be leaders in the development of various imaging techniques to advance treatment planning and ever more precise delivery radiation therapy.
Health Lab
Experts in brain cancer outline current discoveries and offer a path of hope for glioblastoma treatment
Health Lab
At-home test can detect tumor DNA fragments in urine samples, providing a non-invasive alternative to traditional blood-based biomarker tests
Health Lab
Using a chip to process blood samples, doctors can monitor the amount of cancer cells in a patient’s blood to determine how well a treatment is working by the fourth week, according to a new study.
Health Lab
Recently approved by the Food and Drug Administration, Pluvicto is a radionuclide-labelled drug administered to patients showing promising results.
Health Lab
Findings from researchers at the University of Michigan Health Rogel Cancer Center, published in Cancer Discovery, show how a specific nucleotide metabolite called GTP controls responses to radiation and chemotherapy in an unexpected way.
News Release
There are 13 U-M graduate medical education programs ranked in the top 10 by Doximity.
